Sorry for the typos.
They clearly are establishing a total encompassing platform which is forming their leadership in the field.
far exceeds the competition and will be evident as we move forward. They are clearyly established a total encompassing platform leadership in the field.
"At the end of the third quarter, the company brought online a second direct metal 3D printers' manufacturing line and began commercial shipments of its latest consumer printers.
"Now that we have closed these availability gaps, we expect our revenue growth rate to increase," continued Reichental.
Won't have a near term impact and remains to be seen if they can deliever by 2016 and gain any market share at that time. DDD and Stratasys have established themsleves as market leaders and will not be easy to catch. It is HP with the risky move into the space and lagging far behind.
The White House said NASA and the departments of Defense, Energy and Agriculture would invest more than $300 million in the emerging technologies of advanced materials including composites and bio-based materials, advanced sensors for manufacturing, and digital manufacturing.
It said the investments, matched by private-sector resources, would drive advances in the manufacturing of high-tech materials including "new steel alloys that are twice as strong and lighter than today" and new processes to eliminate reliance on foreign supplies of critical materials.
As part of the effort, the National Science Foundation will establish up to two manufacturing "centers of excellence" in basic research bringing together universities and industry with a focus on advanced sensors for manufacturing and digital manufacturing.
Companies specializing in 3-D printing may have been branded the "most hideous" stocks recently, but the sector will continue to produce stellar growth over the coming years, according to latest research.
The size of the global market, including 3-D printer sales, materials and associated services, is predicted to reach $16.2 billion by 2018, according to independent research company Canalys. Its estimates show the sector stood at $2.5 billion globally in 2013 and will rise to $3.8 billion in 2014. And in five years the company believes the market will grow by over 500 percent with a year-over-year growth rate of 45.7 percent.
"We are at the inflection point for 3-D printing," Tim Shepherd, a senior analyst at Canalys said in a press release on Monday afternoon.
Just a little reality to counter the BS #$%$ posted on this board by basher trashers. Their disruptive tech is changing drug discovery by lowering costs and expiditing the discovery process which will bring life changing drugs to market much faster..
Blindness might just be the first major disability to disappear, at least if our high-tech future takes more a utopian than dystopian bent. A bionic eye is already on the market in the United States, and stem cell therapy has been shown to restore sight in mice. Now British scientists have successfully printed retinal cells.
Retinal ganglion at left, towards the front of the eye
Researchers have used 3D printing — an essential part of the effort to produce viable tissue and organs to replace what is damaged — with body cells before, but the process is more successful with some types of cells than others.
In the study, adult retinal ganglion and glial cells of rats were printed using a piezoelectric printer. Most cells emerged undamaged, and the researchers were able to culture the printed cells as successfully as they did cells that had not gone through the printer. Of the cells that first appeared lost in the process, most turned out to be clinging to the printer head.
The Cambridge researchers, Barbara Lorber and Keith Martin, took on a kind of worst-case scenario, using fragile adult cells rather than hardier embryonic cells and a harsher piezoelectric printer rather than its more commonly used cousin, the thermal inkjet.
Glial cells, properly part of the nervous system, are important to study as part of regenerative approaches to blindness because, when activated following injury, they release growth factors that help rewire the connection between the ganglia and the optic nerve, according to the study.
3-D human tissue constructs are organotypic in vitro tissue models of the human corneal epithelium (HCE) used to evaluate the potential ocular irritation of a test material. Tissue viability is determined using the vital dye MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide). The reduction of MTT in treated cultures is expressed as a percentage relative to negative control cultures.
The 3-D ocular constructs are made from human epithelial cells, which are cultured on specially designed cell culture inserts. The cells differentiate to form a multi-layered structure which closely models the corneal epithelium (see picture below).
MTT, a vital dye, is actively taken up by the tissues and subsequently reduced in the mitochondria of living cells. This chemical reaction produces a purple-colored formazan within the cells, causing the live tissues to turn deep purple in color. The colored dye can be extracted from the cells and the absorbance read spectrophotometrically. For specific assay procedures, please see Step-by-Step.
Assay Design: Quick Facts
Assay Model: organotypic 3-D tissue constructs
Endpoint: ET50 (or t50) (the exposure time that induces a 50% reduction in viability, relative to negative controls)
Each assay includes a positive and negative control. For more information about testing your materials using this assay, please see Applications. Specialized protocols may be prepared as requested through consultation with an IIVS Study Director.
So you believe making their first disruptive bio assay product available to the vast global market is a non- event? OK I guess everyone has a different perspective and you are certainly entitled to yours :)
It marks the start or launch of real product sales and revenues. A momentous occasion as it the first of many. Why is it so confusing for you?
That poster creates alias after alias with the intent to trash. A day trading short with the hope of scaring away investors. At times these boards can provide insight. Most times they are used by these lowlife types. It is what it is.